GB0616451D0 - Dna viral infections - Google Patents

Dna viral infections

Info

Publication number
GB0616451D0
GB0616451D0 GBGB0616451.1A GB0616451A GB0616451D0 GB 0616451 D0 GB0616451 D0 GB 0616451D0 GB 0616451 A GB0616451 A GB 0616451A GB 0616451 D0 GB0616451 D0 GB 0616451D0
Authority
GB
United Kingdom
Prior art keywords
viral infections
dna viral
dna
infections
viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0616451.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henderson Morley PLC
Original Assignee
Henderson Morley PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henderson Morley PLC filed Critical Henderson Morley PLC
Priority to GBGB0616451.1A priority Critical patent/GB0616451D0/en
Publication of GB0616451D0 publication Critical patent/GB0616451D0/en
Priority to PCT/GB2007/003181 priority patent/WO2008020243A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
GBGB0616451.1A 2006-08-18 2006-08-18 Dna viral infections Ceased GB0616451D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0616451.1A GB0616451D0 (en) 2006-08-18 2006-08-18 Dna viral infections
PCT/GB2007/003181 WO2008020243A1 (en) 2006-08-18 2007-08-20 Treatment of dna viral infections of the eye

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0616451.1A GB0616451D0 (en) 2006-08-18 2006-08-18 Dna viral infections

Publications (1)

Publication Number Publication Date
GB0616451D0 true GB0616451D0 (en) 2006-09-27

Family

ID=37081217

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0616451.1A Ceased GB0616451D0 (en) 2006-08-18 2006-08-18 Dna viral infections

Country Status (2)

Country Link
GB (1) GB0616451D0 (en)
WO (1) WO2008020243A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4104370A (en) * 1974-07-10 1978-08-01 Smith Kline & French Laboratories Limited Method of treating magnesium/potassium depletion
JPH03240732A (en) * 1990-02-14 1991-10-28 Yasuo Tanaka Antiviral agent
WO2001017528A1 (en) * 1999-09-08 2001-03-15 Nitromed, Inc. Methods of treating and preventing congestive heart failure with hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate
KR100843790B1 (en) * 1999-12-30 2008-07-03 헨더슨 몰리 리서치 앤드 디벨럽먼트 리미티드 Treatment of dna viral infections
AU1873101A (en) * 1999-12-30 2001-07-16 Henderson Morley Research And Development Limited Synergistic treatment of dna viral infections
GB2376628B (en) * 2001-06-19 2005-06-08 Henderson Morley Res & Dev Ltd Treatment of DNA viral infections in cats

Also Published As

Publication number Publication date
WO2008020243A1 (en) 2008-02-21

Similar Documents

Publication Publication Date Title
AP2880A (en) Novel viral factor
ZA200805855B (en) Viral polymerase inhibitors
EP1996730A4 (en) Small rna purification
GB0603160D0 (en) Nucleic acid
ZA201002638B (en) Viral polymerase inhibitors
EP2066418A4 (en) Separation matrix for viral purification
EP2123752A4 (en) Novel nucleic acid
EP2077326A4 (en) Novel nucleic acid
SI2094702T1 (en) Viral inhibitors
EP2185539A4 (en) Viral polymerase inhibitors
EP2073818A4 (en) Enhancing disease resistance against rna viral infections with intracytoplasmic pathogen sensors
IL197023A0 (en) Viral polymerase inhibitors
EP2188274A4 (en) Viral polymerase inhibitors
GB0624302D0 (en) Micro RNA
GB0624227D0 (en) Protein purification
EP2151495A4 (en) Hcv gene
GB0624301D0 (en) Micro RNA
EP1915378A4 (en) Viral polymerase inhibitors
GB201011359D0 (en) Pipettes
GB0720624D0 (en) Viral Modification
GB0616451D0 (en) Dna viral infections
GB0517835D0 (en) DNA viral infections
HU0600159D0 (en) Kvantitative pcr
GB0602625D0 (en) DNA structures
GB0617565D0 (en) Polymerase

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)